gliclazide
英
美
网络 格列齐特; 达美康; 格列奇特; 甲磺吡脲; 格列齐特片
双语例句
- OBJECTIVE To establish a method for the identification of glibenclamide, gliclazide, glimepiride which mixed in a Chinese patent medicine Tangleshu capsules.
目的建立唐乐舒胶囊中非法添加格列本脲、格列齐特、格列美脲成分的鉴别方法。 - Conclusion The sample of Galactosylglucose and Gliclazide can form solid dispersion by high speed grinding.
结论乳糖和格列齐特一定比例下经高速研磨混合的样品形成了共熔体； - A reversed-phase HPLC method was developcd for determination of gliclazide in human serum to study the relative bioavailability of two brands of domestic tablets in10 healthy volunteers.
改进了测定人血清中格列齐特（1）的HPLC方法；在10名健康志愿者体内，研究了两种国产1片剂的相对生物利用度。 - Pharmacokinetics of gliclazide osmotic pump tablets in Beagle dogs
格列齐特渗透泵片在Beagle犬体内的药动学 - CYP reaction phenotyping for Imrecoxib and gliclazide, and induction study of td-0232.
艾瑞昔布和格列齐特代谢酶表型确定与td-0232酶诱导研究。 - The N-amino-1,2-cyclopentane dicarboximide can be used as the intermediate of gliclazide, thereby reducing the reaction route of gliclazide to reduce waste.
本发明的N-氨基-1，2-环戊烷二甲酰亚胺能作为格列齐特的中间体，从而缩短格列齐特的反应路线，有效减少废弃物。 - Clinical observation of type 2 diabetes treatment by use of gliclazide modified release tablets instead of Gliclazide Ordinary Tablets
格列齐特普通片改为格列齐特缓释片治疗2型糠尿病的临床观察 - Preparation of gliclazide sustained-release tablets and influencing factors on its release
格列齐特缓释片的制备及其释药因素考察 - Preparation and Pharmacokinetics in Beagle Dogs of Gliclazide Osmotic Pump Controlled-release Tablets
格列齐特渗透泵控释片的制备及犬体内药动学 - OBJECTIVE To prepare Gliclazide bioadhesive sustained release tablets and investigate the in vitro release characteristics, adhesion in the ex vivo tissues and the pharmacokinetics in beagle dogs.
目的考察格列齐特生物黏附性缓释片体外释药行为，离体组织黏附力，以及在犬体内的药动学。 - A single sweep oscillopolarography method was established for the determination of gliclazide tablets.
建立了单扫描示波极谱法测定格列齐特片的含量。 - OBJECTIVE: To develop a new HPLC method for isolation and determination of gliclazide and its related substances.
目的：建立新的HPLC法分离测定格列齐特片及其有关物质。 - Objective: To study the quality specification of Gliclazide Sustained-release Tablet.
目的：对格列齐特缓释片进行质量标准研究。 - Pharmacokinetics of domestic and imported gliclazide tablets(ⅱ) in healthy volunteers
国产格列齐特片（Ⅱ）在健康人体内的药动学研究 - Aim This study was to compare the bioavailability of two gliclazide sustained release tablets and to investigate the correlation between in vitro release and in vivo absorption of two tablets.
目的：评价两种格列齐特缓释片的药动学及生物等效性，并考察其体外释放度和体内吸收度的相关性。 - Objective To assess the effects of Gliclazide on blood rheology of alloxan induced diabetes Wistar rats.
目的研究格列齐特对四氧嘧啶糖尿病大鼠血液流变学的影响。 - Conclusion Controlled-release-gliclazide had the similar effect on the patients with type 2 diabetes as ordinary gliclazide tablets did in improving their clinical manifestation and quality of life.
结论格列齐特控释片治疗2型糖尿病的临床疗效和对生存质量的影响与格列齐特普通片相似。 - The comparative analysis revealed that gliclazide, glurenorm and glibenclamide were the main oral hypoglycemic agents in our hospital.
临床用药量动态分析表明格列齐特、格列喹酮、格列本脲（优降糖）为武汉协和医院主要的口服降血糖药。 - The therapeutic effects of domestic and imported gliclazide in 81 and 76 patients with NIDDM, respectively were compared during 3-4 mo in this study.
本文对国产和进口格列齐特各治疗81和76例非胰岛素依赖性糖尿病进行为期3－4mo的疗效对比。 - Conclusion: This standard was capable to effectively control the quality of Gliclazide Sustained-release Tablet.
紫外分光光度法测定格列齐特缓释片含量结论：格列齐特缓释片的质量得到有效控制。 - Study on Quality Standard of Gliclazide Sustained-release Tablets
格列齐特缓释片质量标准的研究 - In addition, erythrocyte maximal aggregation index was decreased in gliclazide group.
此外，格列齐特还可降低红细胞最大聚集指数； - Objective To assess clinical efficacy and quality of life ( QOL) for patients of type 2 diabetes treated with controlled-release-gliclazide, as compared with those with ordinary gliclazide tablets, in a randomized controlled clinical trial stage ⅱ.
目的对Ⅱ期随机对照临床试验中应用格列齐特控释片和格列齐特普通片治疗2型糖尿病的临床疗效和生存质量进行比较。 - The top 3 hypoglycemic drugs in respect of sales amount were acarbose, gliclazide, and glipizide.
用药金额排名前3位的药物是阿卡波糖、格列齐特、格列吡嗪。 - Gliclazide was used to treat 106 patients with noninsulin-dependent diabetes mellitus.
应用国产格列齐特治疗非胰岛素依赖型糖尿病106例，并以格列本脲（优降糖）作对照药物。 - 3-azabicyclo [ 3.3.0] octane 1 is a key intermediate of synthesizing gliclazide.
3-氮杂双环[3.3.0]辛烷1是合成格列齐特的关键中间体。 - The quantitative and qualitative models were established by PLS and discriminant analysis for the rabdosia rubescens tablets, gliclazide tablets and ranitidine hydrochloride capsules.
对冬凌草片、格列齐特片和盐酸雷尼替丁胶囊分别用PLS和判别分析建立其定量和定性模型。 - Gliclazide, a second generation sulfonylurea hypoglycaemic agent, is used in the treatment of Type II diabetes mellitus.
格列齐特是第二代磺酰脲类口服降血糖药，用于治疗非胰岛素依赖型糖尿病（Ⅱ型糖尿病）。 - An assessment of internal quality of Gliclazide Tablets, a primary product in diabetes treatment, is completed by analyzing dissolution curves and dissolution parameters by statistics and a process analysis method has also been established in immediate dosage forms and sustained release preparation.
通过对溶出度（释放度）曲线和溶出参数的统计学分析，完成了糖尿病用药的主打产品&格列齐特片的内在质量评价，建立了速释及缓释制剂的过程分析方法。